Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Change in Inventory (2020 - 2025)

Historic Change in Inventory for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $1.8 million.

  • NeuroPace's Change in Inventory rose 12173.91% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 14162.48%. This contributed to the annual value of $2.4 million for FY2024, which is 4240.28% up from last year.
  • According to the latest figures from Q3 2025, NeuroPace's Change in Inventory is $1.8 million, which was up 12173.91% from $2.8 million recorded in Q2 2025.
  • Over the past 5 years, NeuroPace's Change in Inventory peaked at $2.8 million during Q2 2025, and registered a low of -$683000.0 during Q2 2023.
  • Its 5-year average for Change in Inventory is $647315.8, with a median of $362000.0 in 2022.
  • Per our database at Business Quant, NeuroPace's Change in Inventory plummeted by 26905.94% in 2023 and then soared by 2569090.91% in 2025.
  • Over the past 5 years, NeuroPace's Change in Inventory (Quarter) stood at $718000.0 in 2021, then skyrocketed by 62.81% to $1.2 million in 2022, then grew by 29.94% to $1.5 million in 2023, then decreased by 10.99% to $1.4 million in 2024, then soared by 35.8% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $2.8 million for Q2 2025, and $243000.0 during Q1 2025.